Celsion Corp (CLSN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

997 LENOX DRIVE LAWRENCEVILLE, NJ 08648

Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company's product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.

Data as of 2021-08-02 07:47:43 -0400
Market Cap96.079 Million Shares Outstanding86.558 Million Avg 30-day Volume1.121 Million
P/E Ratio-4.34439 Dividend Yield EPS-0.526
Price/Sales192.16 Debt to Equity1.33 EBITDA-18.36 Million
Price to Book Value1.75 Forward PE-3.64 Enterprise Value48.408 Million
Total Cash52.759 Million Current Debt6.69 Million Gross Profit500 Thousand
BETA0.99248 52-week High/Low3.48 / 0.4305 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -16.7421
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CLSN instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 46 32 43.75% 7 (0.41%) 5 (0.29%) 40.0%
13F shares: 11.876 Million 3.199 Million 271.23% 2.609 Million 654.809 Thousand 298.42%
% Ownership 15.8318 8.5496 85.18% 3.478 1.75 98.74%
New Positions: 17 3 466.67% 3 1 200.0%
Increased Positions 10 8 25.0% 2 2 0.0%
Closed Positions 2 14 -85.71% 1 4 -75.0%
Reduced Positions 7 7 0.0% 1 1 0.0%
Total Calls 383.932 Thousand 94.8 Thousand 304.99% 32.6 Thousand 20.9 Thousand 55.98%
Total Puts 342.359 Thousand 70.235 Thousand 387.45% 36.1 Thousand 28.5 Thousand 26.67%
PUT/CALL Ratio 0.89 0.74 20.27% 1.11 1.36 -18.38%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLSN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLSN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PELLIZZARI CHRISTINE A

  • Director
0 2021-06-09 2

LINDBORG STACY

  • Director
40,000 2021-06-04 2

BRAUN DONALD P

  • Director
5,357 2021-05-17 2

TARDUGNO MICHAEL H CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
1,996,071 2021-03-19 1

CHOW POK YU AUGUSTINE

  • Director
183,689 2021-03-19 1

TUMMINELLO TIMOTHY J CONTROLLER

  • Officer
214,557 2021-03-19 1

CHURCH JEFFREY WAYNE CFO

  • Officer
714,951 2021-03-19 1

HOOPER ROBERT W

  • Director
179,737 2021-03-19 1

FRITZ FREDERICK J.

  • Director
180,118 2021-03-19 1

VOSS ANDREAS

  • Director
151,357 2021-03-19 1

MARTINEZ ALBERTO R JR

  • Director
0 2020-06-15 0

BORYS NICHOLAS CMO

  • Officer
0 2019-02-19 0

ANWER KHURSHEED CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-05-15 0

EGWU, INC. FKA EGEN, INC.

  • 10% Owner
2,421,867 2015-12-03 0

LINK MAX

  • Director
0 2014-06-20 0

WEAVER GREGORY L CFO

  • Officer
28,636 2011-12-06 0

PACE GARY W

  • Director
0 2010-02-19 0

MORAN SEAN F. CHIEF FINANCIAL OFFICER

  • Officer
35,000 2009-03-17 0

SUSIE PAUL B. CHIEF ACCOUNTING OFFICER

  • Officer
0 2008-02-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PELLIZZARI CHRISTINE A - Director

2021-06-09 16:20:40 -0400 2021-06-08 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CELSION CORP CLSN 2021-08-05 22:15:04 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 21:45:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 21:15:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 20:45:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 20:15:04 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 19:45:04 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 19:15:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 18:45:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 18:15:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 17:45:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 17:15:03 UTC -2.1809 2.2609 2000000
CELSION CORP CLSN 2021-08-05 16:45:02 UTC -2.1805 2.2605 2000000
CELSION CORP CLSN 2021-08-05 16:15:03 UTC -2.1805 2.2605 2000000
CELSION CORP CLSN 2021-08-05 15:45:03 UTC -2.1805 2.2605 2000000
CELSION CORP CLSN 2021-08-05 15:15:02 UTC -2.1805 2.2605 2000000
CELSION CORP CLSN 2021-08-05 14:45:02 UTC -2.1831 2.2631 2000000
CELSION CORP CLSN 2021-08-05 14:15:04 UTC -2.1831 2.2631 2000000
CELSION CORP CLSN 2021-08-05 13:45:04 UTC -2.1831 2.2631 2000000
CELSION CORP CLSN 2021-08-05 13:15:03 UTC -2.1831 2.2631 2000000
CELSION CORP CLSN 2021-08-05 12:45:03 UTC -2.1831 2.2631 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CLSN -22400.0 shares, $-30912.0 2021-03-31 N-PORT

Elevate your investments